Projects per year
Search results
-
Not started
CS1001/Regorafenib-101: A phase Ib/II multicenter open-label study of CS1001 in combination with regorafenib in patients with advanced or refractory solid tumors
Park, J., Gurney, H., Parshionikar, A., Chapman, N. & Rai, M.
Project: Research